Literature DB >> 3392539

Effects of tetanus toxin on catecholamine release from intact and digitonin-permeabilized chromaffin cells.

M A Bittner1, R W Holz.   

Abstract

Tetanus exotoxin inhibited Ca2+-dependent catecholamine secretion in a dose-dependent manner in digitonin-permeabilized chromaffin cells. The inhibition was specific for tetanus exotoxin and the B fragment of tetanus toxin; the C fragment had no effect. Inhibition required the introduction of toxin into the cell, and was not seen when intact cells were preincubated with the toxin or toxin fragments. The degree of inhibition was related to the length of preincubation with toxin, as well as the concentration of toxin used. A short preincubation with toxin was sufficient to inhibit secretion, and the continued presence of toxin in the incubation medium was not required during the incubation with Ca2+. The inhibition of secretion by tetanus toxin or the B fragment was not overcome with increasing Ca2+ concentrations. Tetanus toxin also inhibited catecholamine secretion enhanced by phorbol ester-induced activation of protein kinase C. Thus, the toxin or a proteolytic fragment of the toxin can enter digitonin-permeabilized cells to interact with a component of the Ca2+-dependent exocytotic pathway to inhibit secretion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3392539     DOI: 10.1111/j.1471-4159.1988.tb01059.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  Amylase release from streptolysin O-permeabilized pancreatic acinar cells. Effects of Ca2+, guanosine 5'-[gamma-thio]triphosphate, cyclic AMP, tetanus toxin and botulinum A toxin.

Authors:  B Stecher; G Ahnert-Hilger; U Weller; T P Kemmer; M Gratzl
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

Review 2.  Getting across the cell membrane: an overview for small molecules, peptides, and proteins.

Authors:  Nicole J Yang; Marlon J Hinner
Journal:  Methods Mol Biol       Date:  2015

3.  Distinct targets for tetanus and botulinum A neurotoxins within the signal transducing pathway in chromaffin cells.

Authors:  P Marxen; F Bartels; G Ahnert-Hilger; H Bigalke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

4.  Isolation, purification, and characterization of fragment B, the NH2-terminal half of the heavy chain of tetanus toxin.

Authors:  M Matsuda; D L Lei; N Sugimoto; K Ozutsumi; T Okabe
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

5.  HID-1, a new component of the peptidergic signaling pathway.

Authors:  Rosana Mesa; Shuo Luo; Christopher M Hoover; Kenneth Miller; Alicia Minniti; Nibaldo Inestrosa; Michael L Nonet
Journal:  Genetics       Date:  2010-11-29       Impact factor: 4.562

6.  Epileptic activity outlasts disinhibition after intrahippocampal tetanus toxin in the rat.

Authors:  M A Whittington; J G Jefferys
Journal:  J Physiol       Date:  1994-12-15       Impact factor: 5.182

7.  Protein kinase C and clostridial neurotoxins affect discrete and related steps in the secretory pathway.

Authors:  M A Bittner; R W Holz
Journal:  Cell Mol Neurobiol       Date:  1993-12       Impact factor: 5.046

8.  Processing of tetanus and botulinum A neurotoxins in isolated chromaffin cells.

Authors:  E Erdal; F Bartels; T Binscheck; G Erdmann; J Frevert; A Kistner; U Weller; J Wever; H Bigalke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

9.  Evidence for a link between specific proteolysis and inhibition of [3H]-noradrenaline release by the light chain of tetanus toxin.

Authors:  D Sanders; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

10.  Immunostaining for oligodendrocyte-specific galactosphingolipids in fixed brain sections using the cholesterol-selective detergent digitonin.

Authors:  Yutaka Matsubayashi; Lena Iwai; Tomohisa Toda; Qing Richard Lu; Hiroshi Kawasaki
Journal:  J Neurosci Methods       Date:  2008-12-03       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.